On the seventh day after STZ injection, the rats in the three T2DM groups lost weight (Figure 5A), fasting blood glucose exceeded 11.1 mmol/L (Figure 5B), and insulin sensitivity decreased (Figure 5C), demonstrating the success of the diabetes model establishment [52,53]. This evidence concerns the gene INS and type 2 diabetes mellitus.